These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11524481)

  • 1. Ischemic stroke outcome: racial differences in the trial of danaparoid in acute stroke (TOAST).
    Hassaballa H; Gorelick PB; West CP; Hansen MD; Adams HP
    Neurology; 2001 Aug; 57(4):691-7. PubMed ID: 11524481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.
    JAMA; 1998 Apr 22-29; 279(16):1265-72. PubMed ID: 9565006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).
    Adams HP; Bendixen BH; Leira E; Chang KC; Davis PH; Woolson RF; Clarke WR; Hansen MD
    Neurology; 1999 Jul; 53(1):122-5. PubMed ID: 10408547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).
    Adams HP; Davis PH; Leira EC; Chang KC; Bendixen BH; Clarke WR; Woolson RF; Hansen MD
    Neurology; 1999 Jul; 53(1):126-31. PubMed ID: 10408548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria.
    Goldstein LB; Jones MR; Matchar DB; Edwards LJ; Hoff J; Chilukuri V; Armstrong SB; Horner RD
    Stroke; 2001 May; 32(5):1091-8. PubMed ID: 11340215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prior aspirin use on stroke severity in the trial of Org 10172 in acute stroke treatment (TOAST).
    Wilterdink JL; Bendixen B; Adams HP; Woolson RF; Clarke WR; Hansen MD
    Stroke; 2001 Dec; 32(12):2836-40. PubMed ID: 11739983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of subtypes of ischemic stroke: history of the trial of org 10172 in acute stroke treatment classification.
    Adams HP; Biller J
    Stroke; 2015 May; 46(5):e114-7. PubMed ID: 25813192
    [No Abstract]   [Full Text] [Related]  

  • 8. Differences between anterior and posterior circulation stroke in TOAST.
    Libman RB; Kwiatkowski TG; Hansen MD; Clarke WR; Woolson RF; Adams HP
    Cerebrovasc Dis; 2001; 11(4):311-6. PubMed ID: 11385210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danaparoid in the prevention of ischemic stroke in paroxysmal nocturnal hemoglobinuria.
    Zyss J; Cakmak S; Derex L; Michallet M; Nighoghossian N
    Cerebrovasc Dis; 2007; 23(5-6):462-3. PubMed ID: 17435387
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic impact of early transcranial Doppler ultrasonography on the TOAST classification subtype in acute cerebral ischemia.
    Wijman CA; McBee NA; Keyl PM; Varelas PN; Williams MA; Ulatowski JA; Hanley DF; Wityk RJ; Razumovsky AY
    Cerebrovasc Dis; 2001; 11(4):317-23. PubMed ID: 11385211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian variation in ischemic stroke subtypes.
    Chaturvedi S; Adams HP; Woolson RF
    Stroke; 1999 Sep; 30(9):1792-5. PubMed ID: 10471425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).
    Adams HP; Woolson RF; Clarke WR; Davis PH; Bendixen BH; Love BB; Wasek PA; Grimsman KJ
    Control Clin Trials; 1997 Aug; 18(4):358-77. PubMed ID: 9257073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Danaparoid for anticoagulation with Cell Saver 5. Answer to the letter of A. Lorentz].
    von Lüpke U
    Anaesthesist; 2001 Oct; 50(10):793. PubMed ID: 11702331
    [No Abstract]   [Full Text] [Related]  

  • 14. Ardeparin and danaparoid.
    Dimens Crit Care Nurs; 2000; 19(4):13-4. PubMed ID: 11998151
    [No Abstract]   [Full Text] [Related]  

  • 15. [Is it safe and cost effective... Danaparoid (Orgaran) as an anticoagulant for mechanical autotransfusion with Cell Saver 5 (Hemonetics),Anaesthesist (2001) 50:26-31].
    Lorentz A
    Anaesthesist; 2001 Oct; 50(10):792. PubMed ID: 11702330
    [No Abstract]   [Full Text] [Related]  

  • 16. [Danaparoid (orgaran) for continuous venovenous hemodiafiltration in a patient with heparin-induced thrombocytopenia].
    Christin F; Theissen-Laval O; Loeb JP
    Ann Fr Anesth Reanim; 1998; 17(1):82-3. PubMed ID: 9750692
    [No Abstract]   [Full Text] [Related]  

  • 17. Immediate use of anticoagulants may not improve stroke outcomes.
    Am J Health Syst Pharm; 1998 Jun; 55(12):1240. PubMed ID: 9640462
    [No Abstract]   [Full Text] [Related]  

  • 18. [Danaparoid sodium].
    Kitazawa Y
    Rinsho Byori; 2011 Feb; Suppl 147():164-6. PubMed ID: 21761765
    [No Abstract]   [Full Text] [Related]  

  • 19. Danaparoid: a review of its use in thromboembolic and coagulation disorders.
    Ibbotson T; Perry CM
    Drugs; 2002; 62(15):2283-314. PubMed ID: 12381232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experiences with Danaparoid sodium. Measures to be taken in heparin-induced thrombocytopenia].
    Anaesthesist; 1998 Nov; 47(11 Suppl Massnahmen):1-4. PubMed ID: 9884734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.